Aurobindo Pharma Q2 FY27: Record Revenue, Profit Up 32.5%
Aurobindo Pharma’s Q2 FY27 net profit rose 32.5% to ₹1,124 crore as revenue hit a record ₹10,263 crore on US and Europe growth and 12 USFDA approvals.
K-NITHYANANDA-REDDY
Aurobindo Pharma’s Q2 FY27 net profit rose 32.5% to ₹1,124 crore as revenue hit a record ₹10,263 crore on US and Europe growth and 12 USFDA approvals.
